arrow
N

Nikolaus Marx

Universitätsklinikum Aachen
H指数:87
被引数:5.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immature Neutrophil Phenotype and Enhanced Myeloperoxidase in Male Patients With Chronic Kidney Disease and Cardiovascular Comorbidity

慢性肾脏病合并心血管并发症男性患者中未成熟中性粒细胞表型及髓过氧化物酶水平升高

2026-08-280
OAAI
PharmaPlain: SOUL trial looking at the effect of oral semaglutide on cardiovascular outcomes in people with type 2 diabetes and atherosclerotic cardiovascular disease and/or chronic kidney disease

PharmaPlain:SOUL试验评估口服司美格鲁肽对伴有2型糖尿病和动脉粥样硬化性心血管疾病和/或慢性肾脏疾病患者心血管结局的影响

2026-08-260
OAAI
CKD disrupts cardiac energy metabolism and aggravates cardiac inflammation, oxidative stress, and dysfunction post-infarction

慢性肾脏病扰乱心脏能量代谢,并加重心肌梗死后心脏炎症、氧化应激和功能障碍

2026-07-240
OAAI
Combination Treatment for Management of Chronic Kidney Disease and Type 2 Diabetes: A Review and Practical Guidance

慢性肾脏病和2型糖尿病管理的联合治疗:综述与实践指南

2026-07-010
PRE
PCSK9 inhibitor treatment and outcomes in patients with atherosclerotic cardiovascular disease but without prior ischaemic events: an observational study

PCSK9抑制剂治疗在无先前缺血事件但患有动脉粥样硬化性心血管疾病患者中的疗效与结局:一项观察性研究

2026-04-160
OA
Prevalence and predictors of high inflammatory risk in heart failure subtypes: findings from the global POSEIDON study

心衰亚型中高炎症风险的发生率及其预测因素:全球POSEIDON研究的结果

2026-01-010
OA
Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study

糖尿病前期缓解与心血管发病率和死亡率:来自糖尿病预防项目结局研究和大庆糖尿病预防结局研究的后续分析

2025-12-120
OA
C-reactive protein and cardiovascular risk in the general population

C-反应蛋白和普通人群中的心血管风险

2025-12-011
PRE